Gbinigie II and Lasserson D |
Clarithromycin-induced akathisia: a class effect of macrolides? |
2016 |
BMJ Case Rep |
pmid:27927708
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Sakurai Y et al. |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. |
2016 |
Adv Ther |
pmid:27432383
|
Inagaki K et al. |
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum. |
2016 |
Intern. Med. |
pmid:27432106
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Laird-Fick HS et al. |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. |
2016 |
Postgrad Med J |
pmid:27222587
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Kim SY et al. |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. |
2016 |
BMC Infect. Dis. |
pmid:27188784
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Ormeci A et al. |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27010145
|
Dubini M et al. |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin. |
2016 |
Ann. Allergy Asthma Immunol. |
pmid:27009438
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Gaüzère BA and Malvy D |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015]. |
2016 |
Bull Soc Pathol Exot |
pmid:26818816
|
Topp E et al. |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. |
2016 |
Sci. Total Environ. |
pmid:27096634
|
Li X et al. |
Macrolides use and the risk of sudden cardiac death. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27086751
|
Boyanova L et al. |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains. |
2016 |
Microb. Drug Resist. |
pmid:26618567
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Cerqueira RM et al. |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? |
2016 |
Obes Surg |
pmid:26467690
|
Boyanova L et al. |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. |
2016 |
Infect Dis (Lond) |
pmid:26465202
|
Nie W et al. |
Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates. |
2015 |
Biomed Res Int |
pmid:26146620
|
Kozan G et al. |
Effect of systemic clarithromycin and prednisolone on histamine-induced otitis media in guinea pigs. |
2015 |
Acta Otolaryngol. |
pmid:26143935
|
Ferro BE et al. |
Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease. |
2015 |
J. Antimicrob. Chemother. |
pmid:26142475
|
Honda M et al. |
Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial. |
2015 |
J. Am. Coll. Surg. |
pmid:26141464
|
Reveiz L and Cardona AF |
Antibiotics for acute laryngitis in adults. |
2015 |
Cochrane Database Syst Rev |
pmid:26002823
|
Ahmed S and Atia NN |
Simultaneous determination of triple therapy for Helicobacter pylori in human plasma by reversed phase chromatography with online wavelength switching. |
2015 |
Spectrochim Acta A Mol Biomol Spectrosc |
pmid:25459696
|
Srivastava AK et al. |
In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation. |
2015 |
Arch. Pharm. (Weinheim) |
pmid:25996140
|
Burton AJ et al. |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824218
|
Kazama I et al. |
Macroscopic haemoglobinuria associated with Mycoplasma pneumoniae infection successfully treated by clarithromycin. |
2015 |
Infez Med |
pmid:25819056
|
Silva JT et al. |
Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: case report and literature review. |
2015 |
Transpl Infect Dis |
pmid:25816889
|
Dinca EB et al. |
The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode. |
2015 |
J. Nerv. Ment. Dis. |
pmid:25629665
|
Liu Q et al. |
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection. |
2015 |
Eur J Gastroenterol Hepatol |
pmid:25629566
|
Genc G et al. |
Does systemic clarithromycin therapy have an inhibitory effect on tympanosclerosis? An experimental animal study. |
2015 |
J Laryngol Otol |
pmid:25619629
|
Galvidis I et al. |
Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes. |
2015 |
Anal. Biochem. |
pmid:25256165
|
Siekmeier R et al. |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections. |
2015 |
Adv. Exp. Med. Biol. |
pmid:25252902
|
Phan TN et al. |
High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. |
2015 |
Int. J. Antimicrob. Agents |
pmid:25499186
|
Adebisi AO et al. |
Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. |
2015 |
J. Pharm. Pharmacol. |
pmid:25496042
|
Tsay FW et al. |
Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. |
2015 |
Helicobacter |
pmid:25495272
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Higuchi K et al. |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study. |
2015 |
Gastric Cancer |
pmid:25098924
|
Shin SH et al. |
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. |
2015 |
PLoS ONE |
pmid:26580072
|
Rose WE et al. |
Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination. |
2015 |
Pharm. Res. |
pmid:24934663
|
Wu IT et al. |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. |
2015 |
World J. Gastroenterol. |
pmid:26457027
|
Barni S et al. |
Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. |
2015 |
J Investig Allergol Clin Immunol |
pmid:25997306
|
Zhu YC et al. |
Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus. |
2015 |
Mol. Cell. Probes |
pmid:26334290
|
Georgopoulos SD et al. |
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era. |
2015 |
Expert Opin Pharmacother |
pmid:26330278
|
Koide T et al. |
Analysis of Distribution of Ingredients in Commercially Available Clarithromycin Tablets Using Near-Infrared Chemical Imaging with Principal Component Analysis and Partial Least Squares. |
2015 |
Chem. Pharm. Bull. |
pmid:26329859
|